Effectiveness of Dry Needling and STM on Pain Management for ACLR
| Status: | Not yet recruiting |
|---|---|
| Healthy: | No |
| Age Range: | 18 - 40 |
| Updated: | 4/26/2018 |
| Start Date: | June 1, 2018 |
| End Date: | December 1, 2019 |
| Contact: | David K Hulsizer, DPT |
| Email: | david.k.hulsizer.mil@mail.mil |
| Phone: | 845-938-5109 |
The Effectiveness of Dry Needling and Soft Tissue Mobilization in the Management of Pain Post ACL Reconstruction: A Randomized Controlled Trial
The purpose of this study is to determine if dry needling (DN) and soft tissue mobilization
(STM) is superior to standard treatment protocol for affecting pain, pain medication usage
and measurements of range of motion (ROM) after ACL reconstruction surgery compared to a
standard treatment protocol. Measurements of pain, pain medication usage, lower extremity
functional scale (LEFS) and ROM will be taken day 2 post op and 1 week, 2 weeks, 3 weeks, and
4 weeks post op. It is hypothesized that the inclusion of DN and STM will acutely decrease
the demand for pain medication and improve objective measurements when compared to a standard
treatment protocol. Findings will potentially lead to insights as to the benefit of applying
these interventions to help decrease the demand for pain medication post-surgery.
(STM) is superior to standard treatment protocol for affecting pain, pain medication usage
and measurements of range of motion (ROM) after ACL reconstruction surgery compared to a
standard treatment protocol. Measurements of pain, pain medication usage, lower extremity
functional scale (LEFS) and ROM will be taken day 2 post op and 1 week, 2 weeks, 3 weeks, and
4 weeks post op. It is hypothesized that the inclusion of DN and STM will acutely decrease
the demand for pain medication and improve objective measurements when compared to a standard
treatment protocol. Findings will potentially lead to insights as to the benefit of applying
these interventions to help decrease the demand for pain medication post-surgery.
Inclusion Criteria:
- Age 18-40 Department of Defense( DOD) beneficiaries (17 if Cadet)
- Scheduled for ACL Reconstruction Surgery
Exclusion Criteria:
- Self-Reported Pregnancy
- History of blood borne pathogens/infectious disease/active infection/metal allergy
- Bleeding disorders or currently taking anti-coagulant medications
- Participants who are not fluent in English
We found this trial at
1
site
Click here to add this to my saved trials
